Reed Smith Client Alerts

Key takeaways

  • On September 6, 2024, the Court of Appeal handed down judgment on claims heard together by insured businesses against insurers in relation to business interruption losses caused by the Covid-19 pandemic
  • In this highly anticipated decision, the Court of Appeal agreed with the lower court on the central issue of causation, albeit by adopting a different approach in reaching that conclusion
  • Decision is a major victory for policyholders whose policies contain “at the premises” wording (not previously considered by the UK Supreme Court)
  • The Court of Appeal agreed with arguments advanced by policyholders that the broader test of causation applied, typically providing a wider degree of coverage for Covid-19 business interruption losses

Background

The Court of Appeal decision in London International Exhibition Centre plc v. Allianz Insurance plc & others considered a series of important preliminary issues in connection with five separate claims by policyholders for business interruption (BI) losses suffered following the pandemic. The initial claims were brought by a variety of businesses, including the owner and operator of the Excel Centre in London and several smaller businesses active throughout the UK, mostly in the hospitality sector.

Each of the claimant parties had similar policy wordings that provide cover for business interruption losses if there is a notifiable disease “at the premises” (ATP). This is the first time that this particular wording has been considered by the English court.

As each claimant policyholder had relatively similar ATP disease wording in their BI insurance policies, the cases were heard together. This approach reflects the English courts’ desire to identify “test cases”, where a single judgment can decide issues affecting a large number of individual policies of a certain type.

In June 2023, the High Court decided in favor of the claimants at first instance. Mr Justice Jacobs held that the causation test applicable to “radius” disease clauses should also be applied to ATP clauses. In reaching this decision, Mr Justice Jacobs applied the reasoning of the UK Supreme Court (UKSC) test case of FCA v. Arch, which we covered in a previous client alert.